Navigation Links
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
Date:8/18/2008

Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

Seattle, WA (PRWEB) August 18, 2008 -- Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

As the demand for increased speed in human clinical trial review, document production and delivery continues, Quorum recognizes the importance of maintaining, implementing and improving robust quality systems. Mr. Malafronte brings with him a wealth of knowledge and experience to help Quorum build upon its market leading innovations while maintaining strict adherence to outstanding regulatory compliance practices. "Mike brings to Quorum the expertise to insure that Quorum's performance remains consistent, reliable and on the cutting edge," explains Cami Gearhart, CEO.

Prior to joining Quorum Review IRB, Mr. Malafronte directed quality groups at Nastech Pharmaceuticals, ICOS Corporation, and Abbott Labs. "It is a pleasure to be heading up the Quality Management and Document Administration teams at Quorum Review," says Mr. Malafronte. "I'm very excited about the on-going work here at Quorum and the outstanding groups that I will direct. My experience managing other quality organizations in the pharmaceutical business provides me with the background necessary to meet our quality goals and deliver documents to our customers in a timely manner."

About Quorum Review
Quorum Review is an independent ethics review board that is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations, guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.    

Quorum's best-in-class service and support includes 3 protocol board meetings a week, daily amendment board meetings, 24 hour site review, 36 hour amendment review, and a secure web portal for online submissions, downloads and submission status review. Quorum can review studies in the US and Canada, review federally funded studies and has a specially designated Phase I study management team.

For information about Quorum Review services:
customerrelations@quorumreview.com
www.quorumreview.com

###

Read the full story at http://www.prweb.com/releases/institutional_review/independent_board/prweb1217544.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SEIU Sending Team to Review Finances at Local 6434, United Long Term Care Workers Union
2. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
3. Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage
4. CVT Announces That FDA Continues to Review Ranexa(R) Applications
5. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
6. Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program
7. ACS Bowers Certified to Provide Utilization Review for State Medicaid Agencies
8. Pediatrics review of underage drinking prevention programs led by Iowa State researcher
9. LCA-Vision Provides Business Update and Market Review
10. 2008 Mitchell Medical Industry Conference Previews 100 Percent Paperless Auto Medical Claim Solution
11. American Scientific Resources, Inc. Discloses Reviewed Financials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... 24, 2017 , ... Castle Farms, the celebrated Northern ... with the winning couple announced on Feb. 14, 2017, on Facebook. The free ... vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... today that it will soon begin franchising throughout the U.S. starting this spring. ... help bring the practice of meditation mainstream. Current Meditation will be the first ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... Calif., Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), ... solutions for the treatment of chronic pain, today reported financial ... 31, 2016. 2016 Accomplishment & Highlights: ... year 2016, an increase of 228% as reported, over the ... 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: